Today I'm speaking with Dr. Mark Pimentel and of course, he's no stranger to anyone in the SIBO community. He's been really instrumental in many IBS and SIBO studies and a lot of research that's been happening over the last few years. I learned about Dr. Pimentel through his book, The New IBS Solution, about 10 years ago. He is the executive director of the Medically Associated Science and Technology program at Cedars-Sinai. He's a professor of medicine at Geffen School of Medicine and associate professor of Cedars-Sinai Medical Center in Los Angeles. He's very active in research and has served as a principal investigator or co-investigator for numerous clinical studies. And of course we know him as the developer or discoverer of the anti-vinculin and anti-CdtB antibodies that predict whether or not you have SIBO or autoimmune IBS. He also discovered the use of Lovastatin for methanogens.
11/21/19 • 33 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-sibo-doctor-podcast-100075/sibo-and-ibs-research-update-with-dr-mark-pimentel-part-1-5282795"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to sibo & ibs research update with dr mark pimentel - part 1 on goodpods" style="width: 225px" /> </a>
Copy